Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    general medicine

    Essential thrombocythaemia

    Also known as: Essential thrombocythemia, Primary thrombocythaemia, Primary thrombocythemia, Essential thrombocytosis

    Essential thrombocythaemia (ET) is a chronic myeloproliferative neoplasm characterised by autonomous platelet overproduction within the bone marrow, predisposing patients to both thrombotic and haemorrhagic complications. Diagnosis requires specialist haematological evaluation to differentiate ET from reactive thrombocytosis or concurrent myeloid disorders. Conventional management involves continuous monitoring and vascular risk mitigation, primarily through antiplatelet or cytoreductive agents. TCM practitioners may provide adjunctive support for symptom management; however, this is supplementary and must not supersede specialist haematological care. Acupuncture and Chinese herbal medicine are not indicated for the reduction of platelet counts, prevention of thromboembolism, or modification of the neoplastic process. The cited evidence includes no studies specific to ET and fails to establish efficacy for TCM interventions in this condition. Safety data extrapolated from acupuncture trials for unrelated conditions (e.g., urinary incontinence) are not applicable to the ET population. The patterns described represent traditional diagnostic frameworks and are not validated clinical subtypes.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Prioritise all haematological consultations and routine pathology; do not alter dosages of aspirin or cytoreductive therapies without specialist instruction.
    • •Maintain optimal hydration within prescribed fluid restrictions and perform regular mobilising exercises during prolonged periods of sedentary activity.
    • •Cessation of smoking is required; patients should work with a general practitioner to manage hypertension, hyperlipidaemia, and glycaemic control.
    • •Maintain a systematic record of fatigue, headaches, sleep patterns, bruising, and bleeding; provide the treating practitioner with a complete and current list of all pharmacological and supplemental interventions.

    Cautions & Contraindications

    See sources
    • •Defer needling during active bleeding, unexplained extensive bruising, suspected thrombosis, fever or acute neurological symptoms. The SUI acupuncture trial [4] does not establish safety in ET, acquired bleeding disorders or patients receiving antithrombotic treatment; this is a precaution, not a trial-derived contraindication.[]
    • •Do not use herbs to replace haematology treatment or start a formula without review of antiplatelets, anticoagulants and cytoreductive medicines. Reference [1] is a broad protocol survey, not ET interaction or efficacy evidence; the specific formula cautions here are conservative clinical precautions.[]
    • •Renal impairment or haematuria requires medical review before herbal treatment; do not extrapolate renal safety from unrelated disease reports. Reference [2] describes PV with IgA nephropathy and supplies neither ET herbal-safety data nor a treatment recommendation.[]

    When to reassess or seek care again

    See sources

    Record baseline fatigue and sleep disturbance on 0–10 scales, functional activity, bruising and bleeding frequency. Review tolerability after every session and overall symptom change after 2–4 weeks; discontinue an ineffective adjunctive trial. Follow blood counts and other investigations only according to the haematology plan, not as proof of a TCM response. New bleeding, persistent worsening symptoms, fever, weight loss or abdominal fullness prompts earlier medical review; acute vascular or neurological symptoms require emergency assessment.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Evidence-based complementary and alternative medicine : eCAM · 2022
    2. Medicine · 2023
    3. The Journal of international medical research · 2021
    4. PloS one · 2016

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.